Medically reviewed by Dr. Anjmun Sharma, MD | Updated 2026-07-164 min read

GLP-1 quality: what a patient can verify

A certificate of analysis may describe certain testing, but its scope, issuer, and relationship to a product vary. It is not a total guarantee and does not replace licensing, prescription labeling, traceability, and pharmacist guidance.

Quick answerQuality verification does not depend on one sheet of paper. Combine public license records, pharmacy identity, prescription labeling, clear instructions, and product-specific questions about available documentation.

What a certificate of analysis can say

A certificate of analysis, when available, may report tests performed on a material or lot. To interpret it, you need to know who issued it, what sample was analyzed, which methods and limits were used, and whether the document relates to the product associated with your prescription.

The document does not by itself establish every step of preparation, storage, and dispensing. It is not FDA approval. Availability or absence of a particular format should be clarified with the pharmacy without treating one answer as a complete quality conclusion.

A four-layer verification

Hold us to this standard

Every check on this page is one you can run on New Hope

Care starts with a $119 review of your history and contraindications by Dr. Anjmun Sharma, MD. If a prescription is appropriate, we name the dispensing pharmacy so you can verify its license before fulfillment, and we say plainly that compounded semaglutide is not FDA-approved, not brand-identical, and that results vary.

See if you are a candidate, free 2-minute quiz
  1. Entity: confirm the active state license and public disciplinary history.
  2. Prescription: check that the label identifies the patient, pharmacy, contents, directions, and an applicable date.
  3. Product: ask what documentation accompanies that prescription or lot and who can explain it.
  4. Use: confirm storage, measurement, administration, and who to call if something looks wrong.

Questions that produce useful answers

Reasons to pause and verify

Pause if you cannot identify a licensed pharmacy, if the product says it is not for human use, if there is no individual prescription, if the label is incomplete, or if the instructions conflict with what you were told. Ask before using it.

FDA BeSafeRx resources

FDA compounding questions and answers

Expanded decision guide

Quality evidence comes in layers

Quality can vary by product, lot, process, storage, handling, and documentation. No single paper answers every question. A useful review combines the pharmacy's legal identity and license, public discipline, the prescription label, product-specific documentation, applicable inspection records, and a clear route for questions or recalls.

RecordWhat it can help showWhat it cannot prove alone
State license recordLegal identity, status, and public disciplineQuality of every preparation or lot
Prescription labelPatient, pharmacy, preparation, directions, and dating informationEvery manufacturing or testing attribute
Certificate or lot documentReported results for named methods, specifications, and sampleUnreported attributes, future lots, clinical effectiveness, or brand identity
Inspection recordObserved conditions and agency findings at a point in timeA permanent guarantee

Questions about sterility and testing are questions, not promises

For an injectable preparation, a patient may ask what product or lot documentation accompanies the prescription, which methods and acceptance criteria are reported, who performed the work, and how a recall would be communicated. The answers vary. Do not treat the existence or absence of one document as a complete quality verdict.

A verification workflow

  1. Get the dispensing pharmacy's exact legal name before payment.
  2. Confirm active state licensing and review public discipline.
  3. Match the delivered label to the prescription and pharmacy record.
  4. Read any document for the exact lot, method, result, date, and limitations.
  5. Ask the pharmacy about damage, storage, unclear directions, adverse events, and recalls.

Warning signs

Pause at anonymous sourcing, altered or incomplete labels, claims that documentation makes a preparation FDA-approved or brand-identical, refusal to identify the pharmacy, guaranteed outcomes, or instructions to use a damaged or unclear product without first contacting the pharmacy.

Primary and official source trail

Read each source for the exact product, population, date, method, and limitation. A source supports only the claim it actually studied or the policy it actually states.

Apply this checklist to New Hope

Every standard on this page is one we hold ourselves to: a $119 physician review with Dr. Anjmun Sharma, MD before any prescription decision, a named dispensing pharmacy you can verify for your location, transparent pricing with medication billed separately (compounded semaglutide from $166/month, tirzepatide from $233/month), and plain disclosure that compounded medications are not FDA-approved, not brand-identical, and that results vary. Telehealth care is available for eligible California patients.

See if you qualify, free 2-min quiz Check availability for your location

Frequently asked questions

What is a certificate of analysis?

It is a document that may report test results for a material or lot. Content and scope vary, so read it with the identity of the issuer and its relationship to the exact prescription.

Does a certificate by itself prove a product is safe?

No. One document does not prove every aspect of preparation, storage, dispensing, or appropriate use, and it does not make a compounded preparation FDA-approved.

What should I verify first?

Start with the pharmacy's active state license and public disciplinary history. Then confirm the pharmacy name on the prescription label and how to contact it.

Does every pharmacy provide the same documentation?

No. Practices vary by pharmacy, product, and prescription. Ask directly what accompanies your product and what the document means.

What if the label or container is unclear?

Do not use the product until you speak with the pharmacy or prescriber. Keep the container and report any reaction or problem through the provided channels.

This article is educational and does not replace an individual medical evaluation. Do not start, stop, or change a medication without speaking with your health care professional.

Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved, not brand-identical, and results vary by individual.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.